Modular phase I/II clinical trial evaluating the selective MET-kinase inhibitor OMO-1 in patients with advanced malignancies: safety and proof of mechanism
Lolkema, MP Plummer, ER De Vos, FYFL Forster, MD Angevin, E Libouban, M Jansen, E Tjwa, M Ciamporcero, E Meulemans, A
Lolkema, MP
Plummer, ER
De Vos, FYFL
Forster, MD
Angevin, E
Libouban, M
Jansen, E
Tjwa, M
Ciamporcero, E
Meulemans, A
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Lolkema MP, Plummer ER, De Vos FYFL, Forster MD, Angevin E, Libouban M, et al. Modular phase I/II clinical trial evaluating the selective MET-kinase inhibitor OMO-1 in patients with advanced malignancies: safety and proof of mechanism. J Clin Oncol. 2019;37(15_suppl):3062-.